Table 2 The correlation between clinical parameters and higher expression of the three pathological parameters [number of cases (%)]
Clinical-Pathology | n | CCR7 | MMP-9 | MMP-2 |
|---|---|---|---|---|
Sex | Â | Â | Â | Â |
Male | 23 | 20 (87.0) | 20 (87.0) | 18 (78.3) |
Female | 18 | 14 (77.8) | 16 (88.9) | 11 (61.1) |
Age | Â | Â | Â | Â |
≤60 years | 33 | 27 (81.8) | 29 (87.9) | 25 (75.8) |
>60 years | 8 | 7 (87.5) | 7 (87.9) | 4 (50) |
Tumor size | Â | Â | Â | Â |
≤3 cm | 16 | 12 (75.0) | 12 (75.0) * | 13 (81.3) |
>3 cm | 25 | 22 (88.0) | 24 (96.0) * | 16 (64) |
Clinical Stage | Â | Â | Â | Â |
Stage I-II | 24 | 18 (75.0) * | 19 (79.2) * | 20 (83.3) * |
Stage III-IV | 17 | 17 (100.0) * | 17 (100.0) * | 9 (52.9) * |
B symptom | Â | Â | Â | Â |
No | 16 | 13 (81.3) | 13 (81.3) | 11 (68.8) |
Yes | 25 | 21 (84.0) | 23 (92.0) | 18 (72) |
Location | Â | Â | Â | Â |
Single location | 14 | 9 (64.3) * | 10 (71.4) * | 12 (85.7) * |
Multiple location | 27 | 25 (92.6) * | 26 (96.3) * | 17 (63) * |